API | relaxin

relaxin Report issue

Animal product Experimental

AACT ChEMBL PubChem

Active Ingredient History

NOW

Relaxin is a protein hormone of about 6000 Da, first described in 1926 by Frederick Hisaw. ^Wikipedia

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecule:
relaxin

More Chemistry

Pharmacology

Mechanism of Action:
Multi-specific: Missing data
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

cervilaxin | relaxin | releasin

Organizations (21)

Research & Development (21)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (5)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (5)

Cardiovascular Diseases (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Heart Failure (Phase 2/Phase 3)

Pre-Eclampsia (Phase 1)

Scleroderma, Systemic (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 7
# of Trial Organizations: 21

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue